Sanjivani Paranteral Limited (BOM:531569)

India · Delayed Price · Currency is INR

192.35

-3.25 (-1.66%)

At close: Aug 17, 2026

-8.21% (1Y)

Market Cap	2.36B -8.2%
Revenue (ttm)	747.28M +4.4%
Net Income	75.46M -7.0%
EPS	6.05 -8.1%
Shares Out	12.28M
PE Ratio	31.77
Forward PE	n/a
Dividend	0.50 (0.26%)
Ex-Dividend Date	n/a

Volume	29,871
Open	193.05
Previous Close	195.60
Day's Range	186.05 - 204.00
52-Week Range	126.00 - 268.80
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ... [Read more]

Industry Pharmaceutical Preparations

Founded 1994

Employees 40

Stock Exchange Bombay Stock Exchange

Ticker Symbol 531569

Full Company Profile

Financial Performance

In fiscal year 2026, Sanjivani Paranteral's revenue was 686.66 million, a decrease of -2.04% compared to the previous year's 700.99 million. Earnings were 67.86 million, a decrease of -16.20%.

Financial Statements